Published 10 months ago • loading... • Updated 10 months ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, CHTR, VIGL on Behalf of Shareholders
NEW YORK, UNITED STATES, JUL 14 – Halper Sadeh LLC investigates NASDAQ deals for securities law breaches and fiduciary duty violations to protect shareholders and seek additional benefits on their behalf.
Halper Sadeh LLC announced investigations on July 14, 2025, into Sage Therapeutics, Charter Communications, and Vigil Neuroscience sales for possible shareholder rights violations.
These inquiries follow concerns about potential breaches of federal securities laws and fiduciary duties during corporate transactions, amid broader investor activism trends.
Halper Sadeh LLC represents defrauded investors globally and has recovered millions through corporate reforms, encouraging shareholders to seek free legal advice.
Sage shareholders will receive $8.50 plus contingent rights worth up to $3.50 per share, Vigil investors $8.00 plus contingent rights up to $2.00 per share, while Charter's terms remain unspecified.
These investigations highlight increasing scrutiny of major deals and suggest ongoing efforts to protect shareholder interests amid complex market and ESG engagement dynamics.